Keep Factually independent
Whether you agree or disagree with our analysis, these conversations matter for democracy. We don't take money from political groups - even a $5 donation helps us keep it that way.
When was Neurocept founded and where is it headquartered?
Executive Summary
Neurocept’s founding date cannot be conclusively determined from the supplied sources because multiple distinct legal entities with the name “Neurocept” appear in public records; evidence points to company activity as early as 2015–2016 but no single, authoritative founding date is present. The most consistent current claim about headquarters ties a Neurocept startup to San Luis Obispo, California in a 2022 profile, while other records list U.S. addresses and a dissolved UK incorporation, producing a fragmented picture that requires direct confirmation from the company or official filings.
1. A San Luis Obispo startup profile that pins a headquarters on California
A company profile lists Neurocept Inc. as a San Luis Obispo, CA, USA startup, describing its nootropic supplements and business aims but omitting a founding date [1]. That profile is the clearest single-item identification of a U.S.-based Neurocept headquarters in the sources provided and frames the enterprise as a consumer supplement company, which aligns with product marketing found on official websites. The startup-entry nature of the listing suggests a small or early-stage company presence in San Luis Obispo; however, the profile’s lack of corporate-registration details or founding-date metadata means the San Luis Obispo headquarters claim rests on a secondary profile rather than on corporate filings. This profile is dated 2022, which provides a timestamp for the headquarters claim but not for company origin.
2. Neurocept’s official marketing materials emphasize “Made in USA” but omit founding details
Neurocept’s official product websites assert that the supplement is “Made in the USA” and provide retail or fulfillment addresses, but these pages do not state a company founding date [2] [3]. The sites focus on product claims, ingredients, and purchasing channels; one site even references Clickbank’s Delaware address for retail processing. Another official page raises a manufacturing-location inconsistency by claiming production in a Canadian, FDA-registered, GMP-certified facility while simultaneously touting U.S. manufacturing [4]. These marketing pages are recent (2025-dated in the analyses), so they reflect the company’s current positioning, yet they are not substitutes for incorporation or registration documents that would settle the founding-date question.
3. Public health provider registry shows a Neurocept LLC with a 2016 identifier and multiple U.S. addresses
A U.S. National Provider Identifier (NPI) registry entry for Neurocept, LLC lists an identifier assigned on June 10, 2016, with practice and mailing addresses in Louisiana and Texas and names an authorized official [5]. That entry indicates a legally recognized U.S. entity operating in clinical neurophysiology services and provides concrete administrative details updated in July 2022. If this NPI entry is the same organization behind the Neurocept supplement brand, then operational existence by 2016 is evidenced, but the NPI taxonomy (clinical neurophysiology) suggests a healthcare-provider focus rather than consumer supplements, raising the possibility that multiple distinct organizations share the Neurocept name.
4. A UK-incorporated Neurocept Limited shows an earlier but short-lived legal existence (2015–2017)
Companies House records show a Neurocept Limited incorporated on November 20, 2015, and dissolved on April 25, 2017 [6]. The UK filing lists an address in Birmingham and was dissolved after failing to file required accounts. This demonstrates that an entity called Neurocept existed in the UK before mid-2017, but its dissolution and missing business-description details mean it is not evidence of continuity with the U.S. Neurocept brand. The UK company’s status as dissolved underscores the risk of conflating separate legal entities that share the same trade name across jurisdictions.
5. Reconciling the fragments: multiple entities with overlapping names create ambiguity
The data presents three plausible but distinct Neurocept identities: a San Luis Obispo startup profile [7], an NPI-registered Neurocept, LLC with a 2016 identifier and U.S. addresses (2022 update), and a dissolved UK Neurocept Limited incorporated in 2015 (dissolved 2017) [1] [5] [6]. Official product websites assert U.S. manufacture but vary on manufacturing location and provide no incorporation date [2] [3] [4]. These discrepancies mean that the name “Neurocept” is not a unique identifier across datasets; the available evidence supports activity under the Neurocept name beginning in 2015–2016 across different jurisdictions, but it does not establish a single founding date or unified headquarters for a single global corporate entity.
6. What remains unresolved and how to confirm the facts reliably
To resolve the founding-date and headquarters question definitively, one must consult primary corporate records: U.S. state incorporation filings for Neurocept Inc., Neurocept LLC, or equivalent trade names; the company’s Articles of Incorporation or Secretary of State records in California or the state where the entity is registered; and authoritative contact information on corporate filings rather than marketing pages. The supplied sources, while recent and useful for location claims and operational timestamps (2015–2025), do not substitute for incorporation documents and leave open the possibility of multiple unrelated Neurocept entities. Direct company disclosure or official registry searches are required for a final, unambiguous answer [1] [2] [3] [4] [5] [6].